ADAGIO THERAPEUTICS INC's ticker is and the CUSIP is 00534A102. A total of 59 filers reported holding ADAGIO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $59,791 | -29.1% | 35,171 | -56.2% | 0.00% | – |
| Q2 2023 | $84,334 | +12.5% | 80,319 | +28.6% | 0.00% | – |
| Q1 2023 | $74,975 | +10.2% | 62,480 | +37.7% | 0.00% | – |
| Q4 2022 | $68,055 | +44.8% | 45,369 | +197.3% | 0.00% | – |
| Q3 2022 | $47,000 | -39.7% | 15,262 | -35.6% | 0.00% | – |
| Q2 2022 | $78,000 | -71.9% | 23,715 | -61.2% | 0.00% | – |
| Q1 2022 | $278,000 | -35.3% | 61,058 | +3.3% | 0.00% | – |
| Q4 2021 | $430,000 | -28.6% | 59,092 | +314.6% | 0.00% | – |
| Q3 2021 | $602,000 | – | 14,252 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 9,248,250 | $15,722,025 | 18.03% |
| Alphabet Inc. | 5,680,785 | $9,657,334 | 0.62% |
| 683 Capital Management, LLC | 4,000,000 | $6,800,000 | 0.53% |
| Bain Capital Life Sciences Investors, LLC | 1,937,207 | $3,293,252 | 0.37% |
| Acuitas Investments, LLC | 208,579 | $354,584 | 0.21% |
| MAVERICK CAPITAL LTD | 5,270,290 | $8,959,493 | 0.20% |
| Orbimed Advisors | 5,270,400 | $8,959,680 | 0.19% |
| Slate Path Capital LP | 3,735,000 | $6,349,500 | 0.18% |
| Redmile Group, LLC | 1,440,725 | $2,449,233 | 0.12% |
| TANG CAPITAL MANAGEMENT LLC | 366,536 | $623,111 | 0.09% |